Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Lupin

    Tag: lupin

    You Searched For "Lupin"
    Lupin launches Ethacrynic Acid Tablets USP, 25 mg

    Lupin launches Ethacrynic Acid Tablets USP, 25 mg

    Medical Dialogues Bureau26 Feb 2020 3:27 PM IST
    The product would be manufactured at Lupin's Nagpur OSD facility, India.
    USFDA completes inspection of Lupins Aurangabad facility

    USFDA completes inspection of Lupin's Aurangabad facility

    Medical Dialogues Bureau17 Feb 2020 4:18 PM IST
    Mumbai: Pharma major Lupin Limited (Lupin) announced the completion of the United States Food and Drug Administration (U.S. FDA) inspection carried...
    Lupin Pithampur unit gets 2 USFDA observations

    Lupin Pithampur unit gets 2 USFDA observations

    Medical Dialogues Bureau13 Feb 2020 12:52 PM IST
    The inspection of the company's Pithampur Unit-I facility by the United States Food and Drug Administration (USFDA) has been completed, Lupin said in...
    Lupin posts net loss at Rs 835 crore in Q3

    Lupin posts net loss at Rs 835 crore in Q3

    Medical Dialogues Bureau8 Feb 2020 10:15 AM IST
    New Delhi: Pharma firm Lupin on Thursday reported widening of its consolidated net loss to Rs 835 crore for the quarter ended December 2019 on account...
    Lupin gets USFDA nod for generic version of Arava Tablets

    Lupin gets USFDA nod for generic version of Arava Tablets

    Medical Dialogues Bureau6 Feb 2020 1:08 PM IST
    Leflunomide Tablets USP is a generic equivalent of Arava Tablets, 10 mg and 20 mg, of Sanofi- Aventis, Lupin said.Mumbai: Pharma major Lupin Limited...
    Lupin Pithampur facilities complete successful MHRA inspection

    Lupin Pithampur facilities complete successful MHRA inspection

    MD bureau28 Jan 2020 2:06 PM IST
    New Delhi: Pharma major Lupin on Monday said the UK Medicines and Healthcare products Regulatory Agency (MHRA), the regulatory agency of the United...
    Lupin Foundation Wins IDMA Corporate Citizen Award 2019

    Lupin Foundation Wins IDMA Corporate Citizen Award 2019

    Medical Dialogues Bureau23 Jan 2020 9:45 AM IST
    Mumbai: Pharma major Lupin Limited (Lupin) recently announced that its corporate social responsibility (CSR) arm, Lupin Foundation, has won the...
    Lupin concludes third edition of medical symposiums for Indian urology community

    Lupin concludes third edition of medical symposiums for Indian urology community

    Medical Dialogues Bureau22 Jan 2020 12:50 PM IST
    Mumbai: Pharma major Lupin Limited (Lupin) recently announced that it has successfully concluded the third edition of its series of medical symposiums...
    Lupin gets 5 USFDA observations for Vizag facility

    Lupin gets 5 USFDA observations for Vizag facility

    Medical Dialogues Bureau20 Jan 2020 11:24 AM IST
    The inspection for the API facility at Vizag closed with five 483 observations, Lupin said. New Delhi: Drug firm Lupin on Saturday said it has...
    Lupin gets 2 observations from USFDA for Nagpur facility

    Lupin gets 2 observations from USFDA for Nagpur facility

    Medical Dialogues Bureau13 Jan 2020 11:58 AM IST
    Drug firm Lupin on Saturday said it has received two observations from the US health regulator following the inspection of its Nagpur manufacturing...
    NPPA fixes retail price of 44 combo drugs including Metformin, Vildagliptin, Paracetamol; Details

    NPPA fixes retail price of 44 combo drugs including Metformin, Vildagliptin, Paracetamol; Details

    Farhat Nasim20 Dec 2019 11:55 AM IST
    New Delhi: Through a recent notification, the apex drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the...
    CDSCO declares 36 samples of Atorvastatin, Metformin, Paracetamol, others as Not of Standard Quality

    CDSCO declares 36 samples of Atorvastatin, Metformin, Paracetamol, others as Not of Standard Quality

    Farhat Nasim25 Nov 2019 3:41 PM IST
    New Delhi: The nodal drug regulatory body, the Central Drugs Standard Control Organization (CDSCO) has declared batches of 36 drugs as not of standard...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok